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DelphiBackground: Communication interventions for childhood vaccination are promising strategies to address
vaccine hesitancy, but current research is limited by the outcomes measured. Most studies measure only
vaccination-related outcomes, with minimal consideration of vaccine hesitancy-relevant intermediate
outcomes. This impedes understanding of which interventions or elements are effective.
It is also unknown which outcomes are important to the range of stakeholders affected by vaccine hesi-
tancy. Outcome selection shapes the evidence base, informing future interventions and trials, and should
reflect stakeholder priorities.
Therefore, our aim was to identify which outcome domains (i.e. broad outcome categories) are most
important to different stakeholders, identifying preliminary core outcome domains to inform evaluation
of three common vaccination communication types: (i) communication to inform or educate, (ii) remind
or recall, and (iii) enhance community ownership.
Methods: We conducted a two-stage online Delphi survey, involving four stakeholder groups: parents or
community members, healthcare providers, researchers, and government or non-governmental organisa-
tion representatives. Participants rated the importance of eight outcome domains for each of the three
communication types. They also rated specific outcomes within one domain (‘‘attitudes or beliefs”)
and provided feedback about the survey.
Results: Collectively, stakeholder groups prioritised outcome domains differently when considering the
effects of different communication types. For communication that aims to (i) inform or educate, the most
important outcome domain is ‘‘knowledge or understanding”; for (ii) reminder communication, ‘‘vacci-
nation status and behaviours”; and for (iii) community engagement communication, ‘‘community partic-
ipation”. All stakeholder groups rated most outcome domains as very important or critical. The highest
rated specific outcome within the ‘‘attitudes or beliefs” domain was ‘‘trust”.
Conclusion: This Delphi survey expands the field of core outcomes research and identifies preliminary core
outcome domains for measuring the effects of communication about childhood vaccination. The findings
support the argument that vaccination communication is not a single homogenous intervention – it has a
range of purposes, and vaccination communication evaluators should select outcomes accordingly.
 2017 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).blanch),
(A. Oku),
J. Kaufman et al. / Vaccine 36 (2018) 6520–6528 65211. Background reflecting their priorities [26–28]. It is not yet known if this isEffective communication with parents and communities is cru-
cial to generating and maintaining demand for vaccines, improving
global vaccination coverage and addressing vaccine hesitancy [1–
7]. Communication strategies for childhood vaccination – here
referred to as ‘vaccination communication interventions’ – operate
at an interpersonal, community or population level and are deliv-
ered in many different ways, including via face-to-face interac-
tions, print, mail/email, phone/SMS, websites, TV and radio,
community events and live performances [8–14]. While varied,
all vaccination communication interventions can be organised
according to an identifiable number of common purposes: to
inform or educate; remind or recall; enhance community owner-
ship of vaccination; teach skills; provide support; facilitate
decision-making or enable communication [9,14]. Organising vac-
cination communication interventions by purpose may aid in
selection of interventions to address identified needs or problems
and assists in drawing together this broad field for study
[8,9,11,12].
Selection of vaccination communication interventions should
ideally be evidence-informed, but it is difficult to estimate effec-
tiveness because implemented interventions are frequently evalu-
ated by measuring inadequate or inappropriate outcomes. A
review of the outcomes measured in 112 controlled trials of vacci-
nation communication interventions showed most trials focused
solely on a limited range of endpoint outcomes, such as vaccination
rates [15], a finding echoed in the final report of the World Health
Organization’s SAGE (Strategic Advisory Group of Experts) working
group on vaccine hesitancy [16]. This is problematic because vacci-
nation communication interventions are often complex, aiming to
do more than increase vaccination rates alone (e.g. some may also
aim reduce decisional conflict or increase knowledge), and they
may be delivered in multi-component packages with other public
health interventions. While obviously critically important, vaccina-
tion rates alone cannot tell us how a vaccination communication
intervention worked, where or why it succeeded or failed, or which
components were effective, essential or even harmful [17–19]. Bas-
ing decisions about intervention selection on a limited range of
outcomes hampers future intervention development or tailoring
and impedes building evidence [20]. For example, there is a funda-
mental ethical argument for ensuring that people not only adhere
to vaccinations, but that their decisions are adequately informed
[21]. Measuring only vaccination-related outcomes cannot reveal
whether these additional goals have been realised.
This is particularly important when evaluating communication
that aims to address vaccine hesitancy. Parents who are vaccine
hesitant fall somewhere in the middle of the continuum between
total vaccine acceptance and complete refusal [16,22]. While they
may fully vaccinate their children, they may still feel some degree
of reluctance or doubt about this decision, making them more
susceptible to misinformation or safety scares [23]. Vaccination
rates alone, therefore, give an incomplete picture of hesitancy
[16,24]. To identify whether vaccination communication interven-
tions can reduce hesitancy, additional relevant outcomes need
consideration.
Vaccine hesitancy affects all stakeholders in child health – par-
ents, healthcare providers, researchers and policymakers [16] –
either personally or through the potential impacts of hesitancy
on vaccination rates and public health. Internationally, different
stakeholder groups are being invited by researchers to identify
the outcomes of key importance for future evaluations of interven-
tions in many other health areas such as cancer, rheumatology and
oral health [25]. These activities have shown that different stake-
holders may rate the importance of outcomes in different ways,the case in vaccine communication. Understanding what outcomes
stakeholders want to achieve or experience may be critical to
designing or delivering future interventions.
1.1. Improving vaccination communication evaluation
One way to help researchers and evaluators select and measure
relevant outcomes is through the development and use of a core
outcome set (COS) [29,30]. A COS is a set of outcomes that stake-
holders agree should be measured, at a minimum, in evaluations
of a condition or intervention [31,32]. Most COSs begin by defining
core outcome domains (i.e. broad categories of what should be
measured). Later COS stages move towards identifying specific out-
comes within these domains and may also establish measurement
methods [33].
In this paper, we describe the identification of preliminary sets
of core outcome domains for vaccination communication, the first
stage of COS development. A recent study has used COS-related
methods to identify ‘core values’ for the evaluation of vaccines
themselves [20], but we are not aware of any comparable research
into the types of outcomes that could be measured in vaccination
communication evaluations.
Because this field is uncharted, our approach was broad. We
focused on three common types of vaccination communication
interventions with potential to address vaccine hesitancy [34],
defined by their purposes: (i) communication to inform or educate,
(ii) to remind or recall, or (iii) to enhance community ownership
[9]. Using an online Delphi survey, we asked different stakeholders
to rate the importance of outcome domains that could be mea-
sured for each communication type. Delphi surveys are commonly
used for outcome prioritisation related to health conditions
[25,26], but the method is largely untested for prioritising commu-
nication outcomes. This study gave us the opportunity to examine
the Delphi survey’s feasibility in the context of vaccination
communication.
This study is the third and final stage in a larger project about
outcomes for vaccination communication [35]. Findings have been
reported on the outcomes measured in trials [15] and the compre-
hensive range of specific outcomes that could be measured within
each outcome domain [36].
2. Aims
Our aims were:
(1) To identify outcome domains that are most important to
stakeholders when measuring the effects of different vacci-
nation communication types.
(2) To explore which specific outcomes within one outcome
domain (‘‘attitudes or beliefs”) are most important to
stakeholders.
(3) To identify and describe patterns in stakeholder responses
relevant to future outcomes research.
(4) To collect feedback on the applicability and acceptability of
the Delphi survey format to prioritise outcome domains for
communication interventions.
3. Methods
We used a Delphi survey to identify stakeholder-relevant out-
come domains for three common types of vaccination communica-
tion. In Delphi surveys, anonymous participants with relevant
expertise answer two or more sequential surveys to identify con-
sensus or convergence [37–39]. We used the Delphi survey to iden-
1 In the published version of the taxonomy, the title of the domain ‘‘communication
elivery and design” was changed to ‘‘Intervention design and implementation,” and
ost” was changed to ‘‘Resource use.” Their definitions and content were not
anged.
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ing participants to reconsider their own views in the second survey
round in light of those of other participants. We anticipated that
this process could lead to convergence towards identifying three
preliminary sets of core outcome domains.
The La Trobe University Human Ethics Committee approved this
study (S16-68).
3.1. Recruitment and participants
There is no consensus on the optimal number of participants for
a Delphi survey [26], and panel sizes are generally guided by prac-
ticality or question scope [40]. Delphi participants are not sampled
for representativeness – rather, they are ‘experts’ drawn from dif-
ferent stakeholder groups to allow comparison and consideration
of different perspectives [41]. Therefore, we used stratified purpo-
sive sampling [42] to recruit participants from four stakeholder
groups: (1) parents or community members; (2) healthcare provi-
ders (both professional and lay health workers); (3) researchers;
and (4) representatives of governmental, inter- or non-
governmental organisations (NGOs). We aimed to reach as many
participants in LMIC settings as possible to ensure the COS would
include global perspectives.
Using email invitations, we directly recruited people associated
with or known to the author team. We also advertised on our
research project’s website [35], shared the link on Twitter and
Facebook parenting groups and through networks with high LMIC
participation (e.g. Healthcare Information for All and the Interna-
tional Union for Health Promotion and Education), and asked par-
ticipants to invite others (i.e. snowballing).
3.2. Delphi structure and administration
We designed and administered the Delphi survey online using
REDCap software (Version 6.7.5) [43]. We understood an online
format might limit participation in LMICs, due to inconsistent
power supply and internet access. We considered paper surveys,
but it was not feasible in the time available. Even with possible
access limitations, an online Delphi enabled broad international
participation, and the digital platform facilitated analysis and com-
munication with participants. Shorter periods between rounds
may improve Delphi survey quality [44], so we administered our
rounds within 2–3 weeks of one another. We collected participant
email addresses separately from survey responses, ensuring anon-
ymity, though this meant participants’ Round 1 and Round 2
responses were not linked. Participants were not identifiable to
one another.
Recruitment materials included the link to Round 1. The Round
2 link was sent to all email addresses from Round 1.
3.3. Generating the survey information
Survey elements are described below. A copy of the survey is
available in Additional File 1.
3.3.1. Outcome domains
Prior to survey administration, we reviewed the vaccination
communication trial and health communication evaluation litera-
ture to identify outcomes potentially relevant to vaccination com-
munication interventions. We also held seven focus groups to
discuss vaccination communication experiences, preferences and
outcomes with parents, researchers, healthcare providers, and gov-
ernment or NGO representatives. We organised all identified out-
comes into a taxonomy of vaccination communication outcomes
[15,36]. This taxonomy delineated the eight outcome domains
presented in the survey: ‘‘knowledge or understanding”, ‘‘attitudesor beliefs”, ‘‘decision-making”, ‘‘vaccination status and
behaviours”, ‘‘health status and well-being”, ‘‘communication
delivery and design”, ‘‘community participation”, and ‘‘cost”1.
3.3.2. Interventions
Vaccination communication includes a broad range of interven-
tions, which we had previously organised into a taxonomy of seven
communication types based on intended purpose [9]. In this study,
we aimed to identify priority outcome domains associated with
three vaccine hesitancy-relevant communication types which were
also most frequently encountered in literature and field work
[8,11,12]: (i) communication to inform or educate; (ii) to remind
or recall; and (iii) to enhance community ownership [9]. We focused
on these three communication types to enable comparison of
stakeholders’ views on the importance of outcomes for different
communication purposes.
3.3.3. Specific outcomes within one domain
We also aimed to investigate whether the Delphi could be used
to rate the importance of the more specific outcomes within one of
the outcome domains: ‘‘attitudes or beliefs” (details in Additional
File 2), chosen because these outcomes have particular relevance
for understanding vaccine hesitancy [16].
3.4. Survey questions
We piloted the survey with a convenience sample of research-
ers and parents to gather feedback on its length and clarity, the
language used and its accessibility on multiple platforms. This
feedback was incorporated into the final design described below.
For each of the three communication types, we asked partici-
pants to rate how important they felt it was to measure outcomes
from each of the eight outcome domains using a 5-point Likert
scale. A rating of 5 meant the domain was considered ‘‘critical”;
3 was ‘‘important but not critical”; and 1 was ‘‘not at all impor-
tant”. We emphasised that participants should rate the outcome
domains from their perspectives (e.g. as parent, as researcher).
They also rated the importance of specific outcomes in the ‘‘atti-
tudes or beliefs” domain. Questions were repeated in both Delphi
Rounds.
In Round 1 only we asked participants to propose and rate addi-
tional outcome domains if they felt these were needed. In both
Rounds, participants could add additional comments after each
question and at the survey’s conclusion. We considered all sug-
gested domains and free text responses carefully. These con-
tributed to our contextual understanding of the survey’s results,
and to our assessment of the survey’s strengths and limitations.
The study’s fourth aim was to examine the viability of the Del-
phi survey as a method for prioritising outcome domains associ-
ated with multiple communication types. At the conclusion of
Round 1, we gathered participant feedback about the clarity of
the survey’s purpose, the description of communication types,
and the description of outcome domains using a 5-point Likert
scale (5 ‘‘very clear”, 3 ‘‘somewhat clear”, 1 ‘‘very unclear”).
3.5. Survey administration
Round 1 was open for three weeks in June 2016. For Round 2,
we sent unique links to all email addresses entered in Round 1.
Some participants who entered their email addresses but did not
complete Round 1 may have participated in Round 2. After Roundd
‘‘C
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group and then, in Round 2, graphically presented the distribution
of scores from 1 to 5 (Fig. 1). We asked participants to review these
graphs for each question and answer them again.
All original outcome domains and outcomes were presented in
both Round 1 to Round 2, regardless of their rating. We considered
additional outcome domains proposed by participants in Round 1
but determined that these fell into existing domains, so no addi-
tional domains were considered in Round 2.
3.6. Data analysis
Using statistical software SPSS (Version 24), we calculated
mean ratings of the outcome domains for each communication
type across all stakeholders and by stakeholder group. We consid-
ered calculating median and inter-quartile range, as the data were
skewed, but this did not illustrate relative differences in rankings
between the domains. Therefore, we calculated the mean but
acknowledge that this may be influenced by outliers.
We analysed specific outcomes in the ‘‘attitudes or beliefs” out-
come domain using the same approach. We compared Round 1 and
Round 2 using paired-sample t-tests and compared stakeholder
ratings using one-way ANOVA with a post-hoc Bonferroni adjust-
ment to identify significant contrasts.
4. Results
4.1. Participant demographics
Some LMIC participants experienced power or internet failures,
which could cause them to exit the survey early, so we included
data for all completed questions. A partial response was recorded
if a participant completed at least one question, but not the entire
survey. In total, we had 178 usable responses (i.e. at least one ques-
tion completed) in Round 1, and 136 (76% of first round) in Round 2
(Table 1).Fig. 1. Example of rating graphs for the outcome domain ‘‘knowledge or understanding
graphs presented to stakeholders in Round 2 summarising the ratings from Round 1.
Table 1
Stakeholder responses in Round 1 and Round 2.
Stakeholder group Round 1
Completed
responses
Partial
responses*
Total usable
responses
(% of total)
% o
gro
Parents 37 11 48 (27%) 8%
Healthcare providers 61 8 69 (39%) 16
Researchers 21 5 26 (15%) 29
Government / NGO representatives 31 4 35 (20%) 37
TOTAL 150 28 178 20
* Partial responses = at least one question completed.Respondents came from 29 countries, with 21% overall residing
in LMICs. An additional 6% lived in HICs but worked on
vaccination-related issues globally or in LMICs. The most
frequently-represented countries were Australia (44%), the United
States (11%), Norway (5%), Nigeria (5%), and Portugal (5%). The high
representation from Australia is likely due to the local networks of
the lead researchers.
4.2. Survey results
For each communication type, we assessed ratings across all
stakeholders (Table 2) and by stakeholder group (Table 3 and Addi-
tional File 3). Since this study is the first effort to develop a COS in
this complex area, we aimed to establish the relative importance of
outcome domains, rather than making an absolute distinction
about which domains should or should not be measured. We have
therefore presented the full list of domains for each communica-
tion type in Table 2 to show differences in ranking order. Any out-
come domain rated 4 or greater was considered very important or
critical. No domain received an average rating of low importance (1
or 2). There were no large changes in the overall ranking order of
the domains between Round 1 and Round 2. Stakeholders tended
to rate all outcome domains higher in Round 2 but the reasons
for this are unclear.
The most important outcome domain for (i) communication to
inform or educate was ‘‘knowledge or understanding”; for (ii)
reminder communication, it was vaccination status or behaviours;
and (iii) for community engagement communication, it was ‘‘com-
munity participation”. Stakeholders rated most outcome domains
as very important or critical, with minimal variation in their prior-
ities across groups (Table 3).
In addition to rating outcome domains for three communication
types, participants rated the importance of specific outcomes
within the domain ‘‘attitudes or beliefs.” All the outcomes were
rated very important (4 or higher) in both survey rounds. Table 4
shows Round 2 mean scores by stakeholder group.” for communication to inform or educate. This figure shows an example of the bar
Round 2
f stakeholder
up from LMICs
Completed
responses
Partial
responses
Total usable
responses
(% of total)
% of stakeholder
group from LMICs
30 3 33 (24%) 9%
% 50 1 51 (38%) 14%
% 25 0 25 (18%) 24%
% 27 0 27 (20%) 48%
% 132 4 136 21%
Table 2
Ratings of outcome domains according to communication type, average across all stakeholder groups.
Communication types All communication types combined
Inform or educate Remind or recall Enhance community ownership
Outcome Domain* Round
1
Round
2
Outcome Domain Round
1
Round
2
Outcome domain Round
1
Round
2
Outcome Domain Round
1
Round
2
Mean±
(SD)
n
Mean
(SD)
n
p Mean
(SD)
n
Mean
(SD)
n
p Mean
(SD)
n
Mean
(SD)
n
p Mean
(SD)
n
Mean
(SD)
n
p
Knowledge or
understanding
4.45
(0.81)
n = 178
4.56
(0.75)
n = 134
– Vaccination status and
behaviours
4.51
(0.72)
n = 157
4.66
(0.65)
n = 133
– Community
participation
4.62
(0.69)
n = 150
4.71
(0.60)
n = 130
– Vaccination status and
behaviours
4.28
(0.87)
n = 487
4.49
(0.73)
n = 397
p < 0.05
Attitudes or beliefs 4.38
(0.89)
n = 177
4.48
(0.72)
n = 133
– Communication
delivery and design
4.12
(0.96)
n = 156
4.24
(0.84)
n = 131
– Attitudes or beliefs 4.40
(0.86)
n = 154
4.67
(0.61)
n = 132
p < 0.05 Attitudes or beliefs 4.24
(0.94)
n = 487
4.40
(0.83)
n = 398
p < 0.05
Vaccination status and
behaviours
4.22
(0.90)
n = 176
4.42
(0.77)
n = 133
p < 0.05 Knowledge or
understanding
3.90
(1.06)
n = 157
4.14
(0.98)
n = 133
– Knowledge or
understanding
4.16
(1.04)
n = 154
4.43
(0.83)
n = 131
– Knowledge or
understanding
4.08
(1.04)
n = 459
4.38
(0.87)
n = 398
p < 0.05
Communication
delivery and design
4.03
(0.97)
n = 175
4.27
(0.83)
n = 134
– Attitudes or beliefs 3.93
(1.00)
n = 156
4.06
(0.98)
n = 133
– Communication
delivery and design
4.28
(0.89)
n = 154
4.39
(0.72)
n = 130
– Communication
delivery and design
4.14
(0.95)
n = 485
4.30
(0.80)
n = 395
p < 0.05
Community
participation
3.86
(1.08)
n = 173
3.99
(0.99)
n = 134
– Community
participation
3.81
(1.09)
n = 154
3.93
(0.99)
n = 130
– Vaccination status and
behaviours
4.11
(0.93)
n = 154
4.37
(0.75)
n = 131
p < 0.05 Community
participation
4.08
(1.04)
n = 477
4.21
(0.95)
n = 394
p < 0.05
Decision-making 4.00
(0.95)
n = 175
3.95
(0.78)
n = 132
– Decision-making 3.90
(1.00)
n = 157
3.92
(0.86)
n = 131
– Decision-making 3.94
(1.00)
n = 153
4.09
(0.73)
n = 130
– Decision-making 3.95
(0.98)
n = 485
3.99
(0.79)
n = 393
Health status and well-
being
3.84
(1.04)
n = 176
3.86
(0.85)
n = 133
– Health status and well-
being
3.65
(1.00)
n = 153
3.80
(0.90)
n = 129
– Health status and well-
being
3.77
(0.97)
n = 150
3.82
(0.85)
n = 131
– Health status and well-
being
3.76
(1.01)
n = 479
3.83
(0.86)
n = 393
–
Cost 3.79
(1.09)
n = 172
3.80
(0.98)
n = 133
– Cost 3.75
(1.09)
n = 150
3.69
(0.93)
n = 129
– Cost 3.75
(1.07)
n = 145
3.75
(0.89)
n = 130
– Cost 3.76
(1.09)
n = 467
3.75
(0.93)
n = 392
–
* Domains listed in descending order for each communication type, based on Round 2 means; ±1 = not important; 2 = somewhat important; 3 = important but not critical; 4 = very important; 5 = critical.
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Table 3
Final round ratings by stakeholder group.
Communication types
Inform or educate Remind or recall Enhance community ownership
Parents
(P)
Healthcare
Providers
(HP)
Researchers
(R)
Govt/
NGO
(G)
Parents
(P)
Healthcare
Providers
(HP)
Researchers
(R)
Govt/
NGO
(G)
Parents
(P)
Healthcare
Providers
(HP)
Researchers
(R)
Govt/
NGO
(G)
Outcome Domain Mean*
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Significant
contrasts±
Mean
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Significant
contrasts
Mean
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Mean
(SD)
n
Significant
contrasts
Knowledge or
understanding
4.64
(0.82)
n = 33
4.65
(0.75)
n = 49
4.28
(0.68)
n = 25
4.56
(0.70)
n = 27
– 4.23
(0.99)
n = 31
4.46
(0.81)
n = 50
3.48
(0.96)
n = 25
4.07
(1.00)
n = 27
R < P
R < HP
4.62
(0.82)
n = 29
4.66
(0.69)
n = 50
3.88
(0.93)
n = 25
4.30
(0.78)
n = 27
R < P
R < HP
Attitudes or beliefs 4.00
(0.94)
n = 33
4.58
(0.61)
n = 50
4.84
(0.37)
n = 25
4.56
(0.58)
n = 25
P < HP
P < R
P < G
3.68
(1.19)
n = 31
4.38
(0.78)
n = 50
3.56
(0.92)
n = 25
4.37
(0.79)
n = 27
P < HP
P < G
R < P
4.50
(0.82)
n = 30
4.76
(0.43)
n = 50
4.56
(0.77)
n = 25
4.78
(0.42)
n = 27
–
Decision-making 3.48
(1.00)
n = 33
4.04
(0.66)
n = 47
4.08
(0.57)
n = 25
4.26
(0.59)
n = 27
P < HP
P < R
P < G
3.68
(0.91)
n = 31
4.12
(0.70)
n = 49
3.50
(1.02)
n = 24
4.22
(0.70)
n = 27
R < HP
R < G
3.80
(1.00)
n = 30
4.21
(0.62)
n = 48
4.08
(0.64)
n = 25
4.22
(0.58)
n = 27
–
Vaccination status
and behaviours
4.16
(0.92)
n = 32
4.46
(0.76)
n = 50
4.60
(0.65)
n = 25
4.50
(0.65)
n = 26
– 4.61
(0.76)
n = 31
4.64
(0.63)
n = 50
4.76
(0.60)
n = 25
4.67
(0.62)
n = 27
– 4.3
(0.75)
n = 30
4.41
(0.79)
n = 49
4.28
(0.79)
n = 25
4.48
(0.64)
n = 27
–
Health status and
well-being
3.73
(1.07)
n = 33
4.02
(0.75)
n = 49
3.64
(0.91)
n = 25
3.92
(0.56)
n = 26
– 3.57
(1.10)
n = 30
4.11
(0.76)
n = 47
3.48
(0.92)
n = 25
3.81
(0.68)
n = 27
R < HP 3.43
(0.90)
n = 30
4.06
(0.83)
n = 49
3.72
(0.74)
n = 25
3.93
(0.78)
n = 27
P < HP
Communication
delivery and
design
3.76
(1.06)
n = 33
4.38
(0.70)
n = 50
4.44
(0.65)
n = 25
4.54
(0.65)
n = 26
P < HP
P < R
P < G
3.70
(1.15)
n = 30
4.37
(0.70)
n = 49
4.32
(0.69)
n = 25
4.56
(0.51)
n = 27
P < HP
P < R
P < G
4.03
(0.98)
n = 29
4.57
(0.58)
n = 49
4.32
(0.63)
n = 25
4.52
(0.58)
n = 27
P < HP
Community
participation
3.82
(1.04)
n = 33
4.08
(0.99)
n = 50
3.76
(1.01)
n = 25
4.23
(0.86)
n = 26
– 3.57
(1.25)
n = 30
4.14
(0.79)
n = 49
3.60
(1.04)
n = 25
4.27
(0.72)
n = 26
P < G 4.47
(0.94)
n = 30
4.67
(0.52)
n = 49
4.88
(0.34)
n = 24
4.89
(0.32)
n = 27
P < G
Cost 3.39
(1.06)
n = 33
3.84
(1.07)
n = 49
3.96
(0.75)
n = 24
4.07
(0.73)
n = 27
P < G 3.23
(0.97)
n = 30
3.98
(0.85)
n = 47
3.48
(0.87)
n = 25
3.89
(0.89)
n = 27
P < HP
P < G
3.23
(0.97)
n = 30
4.02
(0.84)
n = 48
3.72
(0.79)
n = 25
3.89
(0.75)
n = 27
P < HP
P < G
* 1 = not important; 2 = somewhat important; 3 = important but not critical; 4 = very important; 5 = critical; ±Contrasts were significant at the p<0.05 level.
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Table 4
Outcome domain ‘‘attitudes or beliefs”, mean scores across all stakeholders and breakdown to Round 2 scores by stakeholder group.
Specific outcomes Outcome domain: attitudes or beliefs
Parents (P) Healthcare
Providers (HP)
Researchers (R) Govt/NGO (G)
Mean*
(SD)
n Mean(S
D)
n Mean
(SD)
n Mean
(SD)
n Significant contrasts±
Trust 4.29
(1.01)
28 4.80
(0.57)
50 4.83
(0.48)
24 4.96
(0.20)
26 P < HP
P < R
P < G
Attitudes 4.43
(0.94)
30 4.68
(0.55)
50 4.83
(0.38)
24 4.70
(0.61)
27 –
Vaccine acceptance 4.43
(0.90)
30 4.68
(0.47)
50 4.48
(0.59)
25 4.74
(0.45)
27 –
Intention 4.47
(0.90)
30 4.51
(0.62)
49 4.72
(0.54)
25 4.56
(0.75)
27 –
Level of support 4.10
(0.96)
30 4.35
(0.60)
48 3.92
(0.86)
25 4.19
(0.63)
26 –
Confidence 3.53
(0.97)
30 4.43
(0.82)
49 4.16
(0.75)
25 4.12
(0.82)
26 P < HP
P<R
* 1 = not important; 2 = somewhat important; 3 = important but not critical; 4 = very important; 5 = critical; ±Contrasts were significant at the p < 0.05 level.
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stakeholder groups were: 3.96 (0.92) for survey purpose; 3.87
(1.00) for communication descriptions; and 3.69 (0.97) for out-
come descriptions, indicating that participants found these aspects
to be generally clear, though there is room for improvement.5. Discussion
To determine which elements of vaccination communication
interventions are effective and whether they influence vaccine
hesitancy, researchers must measure outcomes that can indicate
whether interventions are impacting other outcomes, such as peo-
ple’s knowledge, beliefs, attitudes or intentions, as well as vaccina-
tion status itself. According to the SAGE Working Group on vaccine
hesitancy, such intermediate outcomes are important because they
can ‘‘indicate important shifts along the vaccine hesitancy contin-
uum” [16]. However these outcomes are not measured by most tri-
als. This Delphi survey is the first step towards systematically
addressing this problem by consulting with stakeholders to priori-
tise outcome domains for future evaluations of common communi-
cation interventions.
The preliminary core outcome domain sets indicate the types of
outcomes that researchers can consider measuring to increase the
likelihood that their evaluations reflect stakeholder priorities and
are able to identify a greater range of relevant intervention effects.5.1. Different types of communication should be assessed using
different intermediate outcomes
When ratings for all three communication types were averaged,
the most highly-rated outcome domain was ‘‘vaccination status
and behaviours”, which is logical and confirms current practice,
as trials essentially always measure outcomes from this domain
[15].
However, when the outcome ratings for different communica-
tion types were considered separately, collective stakeholder
responses clearly showed that they prioritised different intermedi-
ate outcomes for different types of communication. Outcomes
associated with community participation, for example, were rated
as important when evaluating communication strategies that aim
to enhance community ownership and engage the community in
vaccination issues. Social mobilisation strategies are noted as
potentially effective tools to address community-wide vaccinehesitancy [16], but trials rarely measure outcomes such as commit-
tee functionality or level of participation in community coalitions,
which limits the growth of evidence in this area. Similarly, knowl-
edge or understanding outcomes were prioritised for communica-
tion that aims to inform or educate. This finding is important,
because it confirms that communication should not be conceptu-
alised or evaluated as a single (or simple) homogeneous interven-
tion [45]. Trialists could specifically consider the aims of the
communication, and select outcomes reflecting these aims.5.2. Patterns in outcome domain ratings
Across communication types and combining stakeholder
responses, the outcome domain ‘‘communication delivery and
design” was consistently rated relatively highly. This domain
includes many intermediate outcomes related to the perception
and experience of communication. Intermediate outcomes are crit-
ical to providing much-needed information on how a communica-
tion intervention may work [19]. Qualitative research with parents
suggests their impressions of the person delivering vaccination
communication and the timing, format, and delivery setting of
the communication could all influence how they felt and their vac-
cination intentions [46]. The ‘‘health status and well-being” and
‘‘cost” domains were consistently rated as least important, perhaps
because these concepts are not generally associated closely with
communication.
Across stakeholders in both rounds, the average rating was over
4 (‘‘very important”) for all of the specific outcomes within the ‘‘at-
titudes or beliefs” domain. Establishing nuances in the prioritisa-
tion of specific outcomes within a domain likely requires a
Delphi survey that provides more contextual information about
the specific nature and audience of an intervention, and may be a
valuable future topic of investigation.
While we identified a few statistically significant differences in
ratings between stakeholder groups, we are wary of making too
much of these findings because we do not yet know why these
emerged, or the degree to which differences in understanding or
interpretation of the survey may have influenced ratings. Gener-
ally, the similarity of outcome priorities across stakeholder groups
suggests that competing priorities, such as those identified for con-
ditions like rheumatoid arthritis [47], may not be a major issue in
vaccination communication evaluation.
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This study is the first to apply Delphi survey methods to the
study of vaccination communication outcomes, and its successful
administration shows that this is a useful method for establishing
convergence and identifying indicative, relative patterns in ratings
of outcome domains. Future COS research could build on this work,
focusing on specific vaccination communication interventions and
target audiences or adapting the method for other complex,
socially-oriented interventions such as those to promote shared
decision-making [48] and informed consent [49].
This study does not extend to the level of recommending speci-
fic outcomes or outcome measures. However, identifying prelimi-
nary core outcome domains is a critical first step to developing
this area. The findings of this study can be utilised, alongside the
previously-developed detailed taxonomy of vaccination communi-
cation outcomes [36], to help researchers consider additional rele-
vant outcomes for their evaluations and to indicate priority
outcome domains requiring further research to develop appropri-
ate outcome measurement methods.
The online Delphi format was efficient for administration and
analysis, and facilitated broad international participation, includ-
ing from LMICs. While we were limited by time and resource con-
straints, future studies with high LMIC relevance should consider
options which allow translation or physical administration of sur-
veys. We sampled participants purposefully in order to compare
the views of different stakeholder groups, but numbers within
groups were relatively small and their specific views not
generalisable.
We piloted the survey, substantially changing it in response to
feedback. However, participants’ responses suggest that we could
further improve the accessibility of the survey’s language, and
issues with comprehension may have affected some results. For
example, decision-making is a complex topic (itself the subject of
a developing COS [48]) and may have been rated lower as an out-
come domain because it was not readily understood by all partic-
ipants. Conversely, ‘‘community participation” may have been
rated highly for communication to enhance community ownership
because it uses similar wording and ‘‘sounds” appropriate. Never-
theless, the retention rate was relatively high across rounds, and
we received many positive comments from respondents from all
stakeholder groups, suggesting that people were engaged with
the material despite its complexity.
6. Conclusions
This Delphi survey expands the field of core outcomes research
and identifies preliminary core outcome domains for measuring
the effects of communication about childhood vaccination. Vacci-
nation communication interventions impact more than just vacci-
nation status and behaviours. Measuring intermediate outcomes
related to the communication’s purpose is crucial to unpacking
these effects and may assist in understanding the differential
effects of interventions intended to address hesitancy. The findings
support the argument that vaccination communication is not a sin-
gle homogenous intervention – it has a range of purposes, and vac-
cination communication evaluators should select outcomes
accordingly. Trials and evaluations should also consider the poten-
tially different values of stakeholders involved in the communica-
tion intervention, and how these might be reflected by the
outcomes selected for measurement.
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